SUMMARY
dose of 0.15 mg/kg followed by up to three increments of one third of the original dose at intervals of 2 minutes if unconsciousness did not supervene. The initial dose of diazepam was 0.3 mg/kg with up to three increments of one third of the original dose until unconsciousness supervened. Once the patient had become unconscious the anaesthesia was continued with either nitrous oxide and halothane with spontaneous ventilation or with endotracheal anaesthesia with nitrous oxide, muscle relaxant and controlled ventilation.
Midazolam was injected undiluted from the ampoule while diazepam was diluted in water to 1 mg/ml to reduce the pain on injection.
Laboratory Investigations
The following tests were carried out pre-and postoperatively on all patients: full blood examination and platelet count, plasma glucose, sodium, potassium, calcium, chloride, urea, creatinine and aspartate aminotransferase.
The urine was examined microscopically postoperati vely.
Clinical Observations
Respiration was recorded in 25 children receiving midazolam by encircling the lower chest with a sealed air-containing tube and recording the pressure changes in the tube. Chest movement during respiration could thus be recorded. Pulse and systolic blood pressure were monitored at intervals of one minute during induction and increases or decreases of more than 10 mm Hg or 10 beats per minute respectively from the pre-induction level were recorded. When it was available a Dinamap* was used to measure blood pressure. Otherwise a sphygmomanometer and stethoscope were used.
The time from the beginning of injection until unconsciousness occurred, determined by the dropping of a 20 ml syringe filled with water was measured with a stop watch. 8 Following the conclusion of anaesthesia the time until the child responded to verbal commands was measured. At a follow-up visit it was determined whether the child regained memory in the recovery room, where they usually stayed for Yz-l hour after the conclusion of anaesthesia, or following return to the ward. The patients were also asked about hallucinations and other unpleasant sensations. The incidence of vomiting in the recovery room and during the first 2 days postoperatively was ascertained. RESULTS 1. Blood pressure and heart rate changes are summarised in Table 1 sleepiness and unconsciousness. Regular respiration returned after the loss of consciousness.
3. The time of onset of action is recorded in Table 2 . 4. The dose to produce unconsciousness is summarised in TaDle 3. 5. The time after the conclusion of anaesthesia until objective wakening is summarised in 
Laboratory Investigations
The only change seen in the blood and urine tests was a rise in plasma glucose from 4.8 to 5.6 mmolll in the midazolam group from 4.9 to 5.7 mmolll following diazepam.
Special Cases
Children suffering from cerebral palsy, spina bifida, Down's syndrome, muscular 
DISCUSSION
The onset of action of midazolam after injection is more rapid in children than adults. Published work on adults does not record any instances of unconsciousness developing in under 30 seconds. This is to be expected as most drugs, including thiopentone, act more quickly in children. The required dosages, the effects on circulation and respiration and the production of postoperative amnesia is similar in children and adults. The incidence of postoperative vomiting (32070) was higher than in adults (20.5070 in a similar series) but lower than that recorded for 400 patients of similar age having all types of anaesthetics at the Royal Children's Hospital (55070).
The actions of midazolam as used in this trial in children were found to be similar to those of diazepam, despite the slower metabolism and elimination of diazepam. Midazolam has the great advantage that it is water soluble and can be injected without dilution. The necessity for diluting diazepam introduces the possibility of error in dosage and also the injection of a drug in a precipitated form involves the problems of adherence of the precipitate to the walls of the syringe, thereby causing loss of drug and increasing the tendency for the piston to stick.
The rise in plasma glucose observed is consistent with the changes usually seen with anaesthesia and surgery.
In conclusion, midazolam proved to be satisfactory for use as an intravenous induction agent in children over 8 years of age and no significant adverse effects were observed. Patients with osteogenesis imperfecta were resistant to its anaesthetic effect.
